Dynavax Technologies Corp - Company Profile
Powered by 
All the data and insights you need on Dynavax Technologies Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Dynavax Technologies Corp Strategy Report
- Understand Dynavax Technologies Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Dynavax Technologies Corp’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Dynavax Technologies Corp's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Scott Myers
Chairman; Director Executive BoardMr. Scott Myers has been the Director and Chairman of the company since 2021. Most recently he served as the Chief Executive Officer and served on the board of directors at AMAG Pharmaceuticals, Inc. Previously Mr. Myers has served as Chairman of the board of directors of Rainier Therapeutics, Inc.
Ryan Spencer
Chief Executive Officer Senior ManagementMr. Ryan Spencer has been the Chief Executive Officer and a Director of the company since 2019. Prior to this, he served as interim co-President and Senior Vice President, Commercial of the company. Mr. Spencer also served in various position of the company. Prior to this, he served as the Assistant Controller at QRS Corporation.
Kelly MacDonald
Chief Financial Officer Senior ManagementMs. Kelly MacDonald serves as Chief Financial Officer at the company since 2021. Prior to this, she served as Chief Accounting Officer and Vice President of Finance at Ironwood Pharmaceuticals. Previously, she also worked with PricewaterhouseCoopers.
David F. Novack
Chief Operating Officer; President Senior ManagementMr. David Novack has been the President and Chief Executive Officer of the company since 2019. Prior to this, he served as the Senior Vice President, Operations, Quality and interim co-President of the company. Previously, Mr. Novack served in several roles includes Global Head of Technical Operations and Manufacturing Strategy for vaccines at Novartis.
Robert Janssen, M.D.
Chief Medical Officer; Senior Vice President - Clinical Developement Senior ManagementDr. Robert Janssen has been the Chief Medical Officer and the Vice President of Clinical Development of Dynavax since July 2013. Prior to this, He served as the company's Vice President, Medical Affairs since November 2012 and previously served as the Senior Director of Clinical Development at Dynavax from 2010 through 2012. Prior to joining Dynavax, Mr. Janssen served as the Vice President of Medical Affairs at Gilead from 2008 to 2010. Until 2008, Dr. Janssen spent more than 20 years at the US Centers for Disease Control and Prevention (CDC), most recently as the Director of the Division of HIV/AIDS Prevention from 2000 to 2008.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer